Junction Therapeutics logo
VerifiedBiotechnology Research· Founded 2016

Junction Therapeutics

Using the research developed from the laboratory by Matthew Campbell, Trinity College Dublin, we have developed unique technologies for controlled modulation of permeability at the blood brain barrier. Having the potential to revolutionise the treatment of neurological conditions allowing small molecules to enter the brain as treatment as well as allowing pathological molecules to be removed

7-day free trial · no credit card

Employees1 to 10Founded year2016Websitejunctionthx.comLinkedIn profileLinkedIn

Verified contacts

1

available on Kipplo

LinkedIn employees

1 to 10

headcount range

Open roles

no listings

Distinct roles

1

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 1 verified contacts at Junction Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

1 contacts with verified email or phone · masked until revealed.

Sign up free →

No verified contacts on record for this company yet.

Top roles at Junction Therapeutics

1 distinct titles indexed · top 1 shown.

  • 1quality engineer

Sign up to unlock all 1 contacts at Junction Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 1 verified contacts at Junction Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Junction Therapeutics | Kipplo Discover